Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
AbCellera Biologics
AddedFeb 17, 2024
UpdatedJun 28, 2026
AbCellera Biologics

AbCellera Biologics

Public

Vancouver-based AbCellera Biologics researches and develops human antibodies using proprietary technology.

HQ
Vancouver, British Columbia, CA
Founded
2012
Overview
Compare
Fundraising
Employees
Website

Founded in 2012 and headquartered in Vancouver, British Columbia, AbCellera Biologics Inc. is a biotechnology firm specializing in the research and development of human antibodies. The company's core mission is to accelerate the discovery of therapeutic antibodies using its proprietary technology platform, which can develop medical countermeasures within 60 days. AbCellera's platform for single-cell screening, initially developed at the University of British Columbia, focuses on addressing urgent health challenges, including pandemic prevention.

Notable affiliations include partnerships with DARPA's Biological Technologies Office and collaborations with Viking Global Investors and ArrowMark Partners. AbCellera has achieved significant milestones, such as its prominent role in the Pandemic Prevention Platform and its public listing on Nasdaq under the ticker ABCL. With a revenue of $375.2 million in 2021 and a workforce of 386 employees, AbCellera has made substantial contributions to the biotechnology industry, particularly in rapid antibody discovery and development.

AbCellera Biologics - Similar Companies

OmniAb logo

OmniAb

omniab.com

Abterra Biosciences logo

Abterra Biosciences

abterrabio.com

Idbiologics logo

Idbiologics

idbiologics.com

Abalone Bio logo

Abalone Bio

abalonebio.com

argenx logo

argenx

Zebra Biologics logo

Zebra Biologics

Abreos Biosciences logo

Abreos Biosciences

abreos.com

Ancora Biotech logo

Ancora Biotech

ancorabiotech.com

Infinimmune logo

Infinimmune

infinimmune.com

Apriori Bio logo

Apriori Bio

aprioribio.com

Abwiz Bio logo

Abwiz Bio

abwizbio.com

Adimab logo

Adimab

adimab.com

BioClonetics Immunotherapeutics logo

BioClonetics Immunotherapeutics

Abpro logo

Abpro

Vir Biotechnology logo

Vir Biotechnology

vir.bio

AbCellera Biologics - Quick Facts

Who are AbCellera Biologics' competitors?

Companies similar to AbCellera Biologics include OmniAb, Abterra Biosciences, Idbiologics and Abalone Bio.

When was AbCellera Biologics founded?

AbCellera Biologics was founded in 2012.

Where is AbCellera Biologics' headquarters located?

AbCellera Biologics' headquarters is located in Vancouver, British Columbia, CA.

When was AbCellera Biologics' last funding round?

AbCellera Biologics' most recent funding round was for $701M (USD) in May 2023.

How much has AbCellera Biologics raised to-date?

As of May 24, 2023, AbCellera Biologics has raised a total of $1.1B (USD).

How many employees does AbCellera Biologics have?

AbCellera Biologics has 495 employees as of Feb 12, 2024.

AbCellera Biologics - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Antibody Discovery
Tags
  • API
Unique IDs
  • ein: 000000000
  • secCik: 0001703057
  • ticker: ABCL
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research